Cancer Think Tank 2.0

Our Goals for the Evening

1. To gain an understanding of next-generation precision medicine

2. Provide an update on SEngine’s P.A.R.I.S. Test and benefit to patients

3. Understand the role community oncologists play in precision medicine

Our Moderator

Dr. V.K. Gadi, MD, PhD, Associate Member of the Fred Hutchinson Cancer Research Center Clinical Research

Our Speakers

View fullsize

Dr. Anthony Letai, MD, PhD, Associate Professor at the Dana-Farber Cancer Institute

View fullsize

Dr. Christopher Kemp, PhD, Member, Human Biology and Public Health Sciences divisions, Fred Hutchinson Cancer Research Center

View fullsize

Dr. Michael Churchill, PhD, Lead Scientist at SEngine Precision Medicine

View fullsize

Dr. Carla Grandori, MD, PhD, CEO of SEngine Precision Medicine and President and Scientific Director of Cure First

View fullsize

Dr. Marc Loriaux, MD, PhD, Associate Professor of Pathology, School of Medicine at OHSU

We were honored to have had our keynote speaker, Dr. Anthony Letai, a pioneer of Precision, Personalized and Functional Oncology present his latest research and innovations in the use of functional genomics in treating cancer. You can watch his presentation here.

Dr. Carla Grandori’s, MD, PhD, CEO of SEngine Precision Medicine and President and Scientific Director of Cure First presentation, can be viewed here.

Dr. Michael Churchill’s, PhD, Lead Scientist at SEngine Precision Medicine presentation, can be viewed here.

Click here to see the night’s agenda. Plans are already underway for Cancer Think Tank 3.0.

Our Sponsors